Molina Healthcare Slips Into a Loss as Revenue Shrinks and Margins Thin

This Molina Healthcare Inc stock analysis covers a health insurer under pressure. Earnings per share are -$0.68, trailing-twelve-month revenue fell 3.5% to $42.1B, and earnings growth (TTM) is -51.5%. The scoring model’s Quality Score is 31/100 and its signal is Sell.

What Is Happening With the Stock Price

Molina trades at $198.84, in the lower end of a two-year range of $131.72 to $346.71. The shares are well below the high, which tells us that the market has marked down the company’s outlook considerably, but they are also comfortably above the low. The market capitalization is $10.34B. A drop of this size usually reflects worries about profitability, and the data supports those worries.

Quality: Is This a Financially Sound Business?

Margins are thin, as is typical for a managed-care insurer. Gross margin is 8.3% and operating margin is 1.0%, while net profit margin is slightly negative at -0.1%. Return on equity is -1.1%, though return on assets is 1.1%. The two returns have opposite signs, which is unusual and may reflect non-operating items or the timing of earnings, so readers should treat the profitability picture with care.

The cash flow picture is better than the earnings picture. Free cash flow over the trailing twelve months is $416M, a 4.0% yield, even though net income is slightly negative. That is a positive sign in this Molina Healthcare Inc stock analysis, but insurers’ cash flow can swing with the timing of claims payments and premiums, so it may not be repeatable. The balance sheet looks adequate: debt-to-equity is 0.95, the current ratio is 1.69 and the quick ratio is 1.61.

Growth: Does This Company Have Real Upside?

The Growth Score is 25/100. The 5-year revenue CAGR is a healthy 12.4%, but TTM revenue growth is -3.5%, so the business has shifted from expansion to contraction. Earnings growth (TTM) of -51.5% shows profits falling much faster than sales, which is a sign of margin pressure and rising costs against a thin margin cushion. EV/Revenue is 0.14, which is low, but that mostly reflects the low-margin nature of insurance revenue rather than a bargain.

Opportunity: Is Now a Good Time to Enter?

The Opportunity Score is 47/100, the strongest of the three pillars. A P/E ratio is not available because earnings are negative. Price-to-book is 2.49, EV/EBITDA is 16.23 and the free cash flow yield of 4.0% gives some valuation support. The shares sit in the lower end of their two-year range, which a contrarian might see as an opening if profitability recovers. The risk is that earnings fail to recover and the stock falls further. The company pays no dividend.

Molina Healthcare Inc Stock Analysis: The Bottom Line

The bull case: free cash flow of $416M, a reasonable balance sheet, long-run revenue growth of 12.4% a year and a share price well below its two-year high leave room for a rebound if margins recover. The bear case is stronger on the numbers: a net loss, revenue shrinking at 3.5%, earnings growth of -51.5%, and an operating margin of just 1.0% that leaves almost no buffer against higher medical costs or changes in government health programs.

With a Quality Score of 31/100, a Growth Score of 25/100 and an Opportunity Score of 47/100, the Recommendation Score is 34/100 and the model’s signal is Sell. This signal reflects StreetBriefs’ quantitative scoring model and is a starting point for further research, not a personalized recommendation to transact.